Organigram Holdings | OGI - 债务



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 157.76M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


债务 更改 日
Acasti Pharma USD 0 0 2024-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Avita Medical AUD 46.05M 1.46M 2025-12
Canopy Growth CAD 278.71M 19.38M 2026-03
Cronos Group USD 1.31M 198K 2026-03
Dianthus Therapeutics USD 1.36M 79K 2026-03
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
IQVIA Holdings USD 16.24B 408M 2026-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Moderna USD 1.3B 7M 2026-03
Organigram Holdings CAD 8.2M 554K 2026-03
Organon & Co USD 8.55B 16M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 13.35B 993.3M 2026-06
Xeris Pharmaceuticals USD 258.55M 899K 2026-03